William Hait - Jan 3, 2022 Form 3/A Insider Report for JOHNSON & JOHNSON (JNJ)

Role
Title: EVP, Chief External Innovation and Medical Officer
Signature
/s/ Raavi Deol, as attorney-in-fact for William Hait
Stock symbol
JNJ
Transactions as of
Jan 3, 2022
Transactions value $
$0
Form type
3/A
Date filed
2/12/2024, 04:19 PM
Date Of Original Report
Jan 13, 2022
Next filing
Feb 18, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
holding JNJ Common Stock 16K Jan 3, 2022 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This Form 3/A is being filed to correct the number of shares of common stock reported in Table I of the original Form 3 filed on January 13, 2022, as amended by the Form 3/A filed on February 18, 2022 ("Amended Form 3"), which Amended Form 3 inadvertently reported 71,609 shares beneficially owned by the reporting person instead of the 15,996 shares reported herein. This Form 3/A is deemed to update the number of securities reported as beneficially owned in any Forms 4 subsequently filed by the reporting person through the date hereof.

Remarks:

Title: EVP, Chief External Innovation and Medical Officer